Key facts
- This page summarizes William K. Fleming's Form 4 filing for HUMANA INC (HUM).
- 0 reported transactions and 9 derivative rows are listed below.
- Accepted by SEC: 30 Sep 2024, 12:01.
William K. Fleming - 30 Sep 2024 Form 4 Insider Report for HUMANA INC (HUM)
- Reporting relationship
- Chief Corporate Aff. Officer
- Issuer ticker
- HUM
- Reported as of
- 30 Sep 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 30 Sep 2024, 12:01:10 UTC
- Prior SEC filing
- 23 Feb 2024
- Source filing
- View source filing
- Reporting owner signature
- William K. Fleming
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
William K. Fleming filed Form 4 for HUMANA INC (HUM) on 30 Sep 2024.
Change
- Previous filing in this sequence was filed on 23 Feb 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
HUM
holding
Humana Common
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 11,723
- Date
- 30 Sep 2024
- Ownership
- Direct
- Footnotes
- F11
HUM
holding
Humana Common
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 121
- Date
- 30 Sep 2024
- Ownership
- See Footnote
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
HUM
holding
Derivative
Options
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 324
- Date
- 30 Sep 2024
- Ownership
- Direct
- Underlying class
- Humana Common
- Underlying amount
- 324
- Exercise price
- $307.96
- Footnotes
- F2
HUM
holding
Derivative
Options
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 2,149
- Date
- 30 Sep 2024
- Ownership
- Direct
- Underlying class
- Humana Common
- Underlying amount
- 2,149
- Exercise price
- $350.79
- Footnotes
- F3
HUM
holding
Derivative
Options
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 4,807
- Date
- 30 Sep 2024
- Ownership
- Direct
- Underlying class
- Humana Common
- Underlying amount
- 4,807
- Exercise price
- $376.61
- Footnotes
- F4
HUM
holding
Derivative
Options
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 3,750
- Date
- 30 Sep 2024
- Ownership
- Direct
- Underlying class
- Humana Common
- Underlying amount
- 3,750
- Exercise price
- $425.06
- Footnotes
- F5
HUM
holding
Derivative
Options
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 3,698
- Date
- 30 Sep 2024
- Ownership
- Direct
- Underlying class
- Humana Common
- Underlying amount
- 3,698
- Exercise price
- $510.24
- Footnotes
- F6
HUM
holding
Derivative
Options
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 5,389
- Date
- 30 Sep 2024
- Ownership
- Direct
- Underlying class
- Humana Common
- Underlying amount
- 5,389
- Exercise price
- $367.21
- Footnotes
- F7
HUM
holding
Derivative
Restricted Stock Units
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 345
- Date
- 30 Sep 2024
- Ownership
- Direct
- Underlying class
- Humana Common
- Underlying amount
- 345
- Exercise price
- Footnotes
- F8, F9
HUM
holding
Derivative
Restricted Stock Units
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 639
- Date
- 30 Sep 2024
- Ownership
- Direct
- Underlying class
- Humana Common
- Underlying amount
- 639
- Exercise price
- Footnotes
- F8, F10
HUM
holding
Derivative
Phantom Stock Units
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 24
- Date
- 30 Sep 2024
- Ownership
- See Footnote
- Underlying class
- Humana Common
- Underlying amount
- 24
- Exercise price
- Footnotes
- F12
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Section 16 status
William K. Fleming is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Explanation of responses 12 footnotes
Footnote F1
Shares held for the benefit of reporting person as of August 31, 2024 under the Humana Retirement Savings Plan including routine payroll deductions, quarterly dividend allocation, and a routine disposition of shares to fund an administrative fee assessment under a Tax-Conditioned Plan, exempt under Rule 16b-3(c).
Footnote F2
Right to buy pursuant to Company's 2011 Stock Incentive Plan. Non-Qualified stock options granted to reporting person on 02/25/2019, vesting in three increments from 2/25/20 to 2/25/22.
Footnote F3
Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/24/2020, vesting in three annual increments from 2/24/21 to 2/24/23.
Footnote F4
Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 2/22/2021, vesting in three annual increments from 2/22/22 to 2/22/24.
Footnote F5
Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/21/2022, vesting in three annual increments from 2/21/23 to 2/21/25.
Footnote F6
Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/24/2023, vesting in three annual increments from 2/24/24 to 2/24/26.
Footnote F7
Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/21/2024, vesting in three annual increments from 2/21/25 to 2/21/27.
Footnote F8
Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).
Footnote F9
Restricted stock units granted to reporting person on 02/21/2022, 33% of the award is vesting on 12/15/22, 12/15/23, and 12/15/24.
Footnote F10
Restricted stock units granted to reporting person on 02/24/2023, 33% of the award is vesting on 12/15/23, 12/15/24, and 12/15/25.
Footnote F11
Includes 1,396 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan.
Footnote F12
Phantom Stock Units held for the benefit of reporting person as of August 31, 2024 based on the value of Humana common stock on a 1-for-1 basis, under the Humana Retirement Equalization Plan. The ending number of units reflects normal fluctuation due to changes in stock price.